Family Milk Product Two-year Dose-response Study to Enhance Bone Health
FAMILY
FAMILY (FAmily MILk Product Two-Year) Dose-response Study to Enhance Bone Health
1 other identifier
interventional
94
1 country
1
Brief Summary
The final stages in the development of peak bone mass (PBM) reside in late adolescence or early adulthood and are critical in the achievement of bone health. Optimization of PBM and maintenance of bone mineral density (BMD) are the best population health strategies in the primary prevention of osteoporosis. Diet and activity are key lifestyle factors in the primary prevention of osteoporosis as recognized in Canada's Food and Activity Guides. Dietary Reference Intakes are evidence-based regarding nutrition and bone health with a focus on calcium and vitamin D; yet the Food Guide and health behaviors are reliant on actual foods. The number of recommended servings of milk and alternatives varies by age with average intakes estimated to be below targets for all Canadians \> 9 y of age. This is especially concerning during development of PBM. Therefore, the global objective is to generate high-level evidence that dietary intervention with milk and milk products will enhance PBM in young men and women and maintenance of BMD in their parents. The primary objective is to demonstrate in healthy young men and women (14-18.9 y at baseline) with habitually low usual milk and milk product intakes that intervention with greater milk and milk product consumption improves lumbar spine BMD in a dose-response manner over 2 y (while accounting for body size, physical activity, demographics and age). Healthy young men and women will be recruited and screened for usual intake of milk and milk products. Those with low intakes \< 2 servings of milk or milk products will be randomized (stratified by sex and age) to 1 of 3 groups for the RCT (n=10090/group): maintain usual low intakes (\<1 serving), improved intakes (average of 2 servings/d) or recommended intakes (≥3 servings/d) of milk and milk products. A manualized motivational interviewing framework will be used for the interventions. Those meeting recommendations at screening will form a longitudinal cohort for 2 y. Key measurements include baseline and yearly assessment of BMD at multiple sites plus interim assessment of general health, anthropometry, dietary intakes, physical activity and biomarkers of calcium homeostasis; and in the young adults bone metabolism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started May 2014
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 4, 2014
CompletedFirst Posted
Study publicly available on registry
September 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2019
CompletedFebruary 5, 2020
February 1, 2020
5.6 years
September 4, 2014
February 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in lumbar spine BMD (g/cm2) at 2 years.
To examine in healthy young men and women (14-18.9 y at baseline) with habitually low usual milk and milk product intakes (\<1 serving/d) whether intervention with greater milk and milk product consumption improves lumbar spine (LS) BMD at 2 years in a dose-response manner.
up to 2 years
Secondary Outcomes (5)
Change in calcium homeostasis at 2 years.
up to 2 years
Change in whole body BMD (g/cm2) at 2 years
up to 2 years
Change in total hip BMD (g/cm2) at 2 years.
up to 2 years
Change in distal forearm BMD (g/cm2) at 2 years.
up to 2 years
Change in femoral neck BMD (g/cm2) at 2 years.
up to 2 years
Study Arms (3)
Control
NO INTERVENTIONMaintain current milk and milk product intakes.
2 servings
ACTIVE COMPARATORParticipants will be asked to consume 1 milk (250 ml) plus a yogurt (100-175 g) or cheese (up to 50 g) to reach an average of 2 servings of milk or milk products/d.
4 servings
ACTIVE COMPARATORParticipants will be asked to consume recommended servings of milk or milk products/d for their age, so they will receive 1 milk (250 ml), a yogurt (175 g) and cheese (50 g) or more. This would provide ≥ 3 servings/d.
Interventions
Participants will receive motivational counseling to help the improve milk and milk product intakes to 2 servings per day.
Participants will receive motivational counseling to help them increase their milk and milk product intake to 4 servings per day.
Eligibility Criteria
You may qualify if:
- to 18.9 y of age at onset of the intervention
- reside with their parents
- consume \< 1 serving/d of milk and milk products
- \> 2 y post-menarche
- non smoker
- not routinely taking prescribed oral medication including oral/dermal
- healthy body mass index (BMI) defined as ± 1SD of 50% percentile WHO curves
- normal bone mass for age/sex
- adequate vitamin D status (\>30 nmol/L 25(OH)D)
- no anemia
- receptive to stop any nutritional supplements 2 weeks prior to and during the study.
You may not qualify if:
- Any known chronic disease with exception of mild asthma (\<500 µg budesonide) that does not affect BMD Z-scores
- Anaemic (defined as Hg \<13.5 g/dL in males and \<12.0 g/dL in females for their age group).
- Known allergies or aversions to milk and milk products
- Anticipating becoming pregnant or a moving distant from Montreal or from family home in the next 2 y.
- Have preference for non-dairy alternatives
- consume ≥2 alcoholic beverages/day
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McGill Universitylead
- Dairy Farmers of Canadacollaborator
Study Sites (1)
Mary Emily Clinical Nutrition Research Unit
Sainte-Anne-de-Bellevue, Quebec, H9X2E3, Canada
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Hope A Weiler, PhD
McGill University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 4, 2014
First Posted
September 11, 2014
Study Start
May 1, 2014
Primary Completion
December 20, 2019
Study Completion
December 20, 2019
Last Updated
February 5, 2020
Record last verified: 2020-02